Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.11)

# 2,884

Out of 5,173 analysts

5

Total ratings

50%

Success rate

14.39%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic

Stocks Rated by Matt Dellatorre

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TEVA Teva Pharmaceutical Industries	Maintains: Buy	$36 → $45	$28.77	+56.41%	4	Feb 9, 2026
	VTRS Viatris	Initiates: Neutral	$10	$13.29	-24.76%	1	Jun 6, 2025

Teva Pharmaceutical Industries

Feb 9, 2026

Maintains: Buy

Price Target: $36 → $45

Current: $28.77

Upside: +56.41%

Viatris

Jun 6, 2025

Initiates: Neutral

Price Target: $10

Current: $13.29

Upside: -24.76%